Newsroom

Contact Us

Corporate Contact Investor Relations Human Resources General Inquiries

QIAsymphony system
Diverse appeal
Read interviews
HUMAN ID
Looking to the future of missing persons analysis
with NGS
Read story
Latent Tuberculosis
"Like smoldering ember that
can catch fire again"
Read Interview
NEXt-Generation sequencing
Enabling the fight against cancer
Read Feature
RNA research
Cracking
the code
Read story

Latest press releases

SUBSCRIBE TO RSS-FEED

06.09.2017
QIAGEN N.V. announces successful completion of non-U.S. offer involving convertible notes
READ MORE
06.09.2017
Ad-hoc announcement pursuant to Art. 17 MAR
READ MORE
21.08.2017
QIAGEN and Clinical Genomics partner on liquid biopsies to monitor patients for recurrence of colorectal cancer
READ MORE
09.08.2017
Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 (MAR) and the Delegated EU Regulation 2016/1052 / Share Repurchase
READ MORE
27.07.2017
QIAGEN reports results for second quarter and first half of 2017
READ MORE
22.06.2017
DiaSorin and QIAGEN sign collaboration to expand liaison test menu through adoption of select QIAGEN assays
READ MORE
22.06.2017
French health-system approves reimbursement of QIAGEN's QuantiFERON latent TB test
READ MORE
08.06.2017
QIAGEN's QuantiFERON®-TB Gold Plus gains U.S. FDA approval
READ MORE
06.06.2017
QIAGEN receives U.S. FDA approval for cytomegalovirus (CMV) testing on automated QIAsymphony platform
READ MORE
03.06.2017
Bristol-Myers Squibb and QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies
READ MORE

SEE ALL RELEASES

Financial information

Financial reports teaser

Financial reports

Events and presentations

Featured resources

SEE ALL RESOURCES

Media library

Library teaser

Photo archive

Library teaser

Video footage

Our social media channels

Visit our Social Hub

Looking for more information?

SOCIAL SHARING

LANGUAGE

OTHER WEBSITES

© QIAGEN 2013 - 17. All rights reserved